EVALUATION OF A SOMATOSTATIN ANALOG (SMS-201-995, SANDOSTATIN(R)) IN THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMAS (NHL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - RESULTS OF A PHASE-II NORTH CENTRAL CANCER-TREATMENT GROUP (NCCTG) TRIAL

Authors
WITZIG TE GERSTNER J MAILLIARD JA SCHROEDER G
Citation
Te. Witzig et al., EVALUATION OF A SOMATOSTATIN ANALOG (SMS-201-995, SANDOSTATIN(R)) IN THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMAS (NHL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - RESULTS OF A PHASE-II NORTH CENTRAL CANCER-TREATMENT GROUP (NCCTG) TRIAL, Blood, 84(10), 1994, pp. 10000169-10000169
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
84
Issue
10
Year of publication
1994
Supplement
1
Pages
10000169 - 10000169
Database
ISI
SICI code
0006-4971(1994)84:10<10000169:EOASA(>2.0.ZU;2-2